Short term treatment with a cocktail of rapamycin, acarbose and phenylbutyrate delays aging phenotypes in mice
Abstract Pharmaceutical intervention of aging requires targeting multiple pathways, thus there is rationale to test combinations of drugs targeting different but overlapping processes. In order to determine if combining drugs shown to extend lifespan and healthy aging in mice would have greater impa...
Main Authors: | Zhou Jiang, Juan Wang, Denise Imai, Tim Snider, Jenna Klug, Ruby Mangalindan, John Morton, Lida Zhu, Adam B. Salmon, Jackson Wezeman, Jiayi Hu, Vinal Menon, Nicholas Marka, Laura Neidernhofer, Warren Ladiges |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-11229-1 |
Similar Items
-
Rapamycin, Acarbose and 17α-estradiol share common mechanisms regulating the MAPK pathways involved in intracellular signaling and inflammation
by: Lily Wink, et al.
Published: (2022-02-01) -
Identification of enzymes involved in oxidation of phenylbutyrate
by: Neža Palir, et al.
Published: (2017-05-01) -
Metabolic syndrome treatment: focusing on acarbose
by: I. E. Chazova, et al.
Published: (2008-04-01) -
Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease
by: Arnold, SE, et al.
Published: (2024) -
Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease
by: Steven E. Arnold, et al.
Published: (2024-07-01)